We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Top Buys

Rank Stock Value
1
PLAY icon
Dave & Buster's
PLAY
+$2.84M
2
LYV icon
Live Nation Entertainment
LYV
+$2.81M
3
WWW icon
Wolverine World Wide
WWW
+$2.72M
4
TSLA icon
Tesla
TSLA
+$2.63M
5
CALY
Callaway Golf Company
CALY
+$2.58M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.61M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.99M
3
EXTR icon
Extreme Networks
EXTR
+$2.33M
4
CASY icon
Casey's General Stores
CASY
+$2.21M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTWO icon
1801
Q2 Holdings
QTWO
$3.92B
– –
-29,183
Closed -$1.13M
RBA icon
1802
RB Global
RBA
$17.5B
– –
-9,369
Closed -$610K
RCUS icon
1803
Arcus Biosciences
RCUS
$3.64B
– –
-9,888
Closed -$251K
RDHL
1804
Redhill Biopharma
RDHL
$3.68M
– –
-17
Closed -$14K
REAL icon
1805
The RealReal
REAL
$1.5B
– –
-246,635
Closed -$614K
REI icon
1806
Ring Energy
REI
$339M
– –
-84,427
Closed -$225K
REPL icon
1807
Replimune Group
REPL
$1.01B
– –
-59,430
Closed -$1.04M
RGLD icon
1808
Royal Gold
RGLD
$19.5B
– –
-5,230
Closed -$558K
RGR icon
1809
Sturm, Ruger & Co
RGR
$593M
– –
-5,289
Closed -$337K
RHI icon
1810
Robert Half
RHI
$4.37B
– –
-3,643
Closed -$273K
RITM icon
1811
Rithm Capital
RITM
$5.69B
– –
-36,959
Closed -$344K
RJF icon
1812
Raymond James Financial
RJF
$34B
– –
-4,955
Closed -$443K
RLAY icon
1813
Relay Therapeutics
RLAY
$4.33B
– –
-178,593
Closed -$2.99M
ROG icon
1814
Rogers Corp
ROG
$2.4B
– –
-1,961
Closed -$514K
RPRX icon
1815
Royalty Pharma
RPRX
$25.3B
– –
-12,874
Closed -$541K
RRX icon
1816
Regal Rexnord
RRX
$11.9B
– –
-11,994
Closed -$1.36M
RS icon
1817
Reliance Steel & Aluminium
RS
$21.6B
– –
-3,364
Closed -$571K
RVMD icon
1818
Revolution Medicines
RVMD
$44B
– –
-42,184
Closed -$822K
RXT icon
1819
Rackspace Technology
RXT
$1.24B
– –
-63,535
Closed -$456K
SACH
1820
Sachem Capital Corp
SACH
$39.8M
– –
-13,579
Closed -$55K
SCHW
1821
Charles Schwab
SCHW
$187B
– –
-6,383
Closed -$403K
SDGR icon
1822
Schrodinger
SDGR
$1.36B
– –
-29,512
Closed -$779K
SEDG icon
1823
SolarEdge
SEDG
$1.95B
– –
-980
Closed -$268K
SEMR
1824
DELISTED
Semrush
SEMR
– –
-19,342
Closed -$250K
SFL icon
1825
SFL Corp
SFL
$1.61B
– –
-37,963
Closed -$360K
71 72
73
74 75

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.